China Shineway Pharmaceutical Group (HKG:2877) recorded a turnover of 2.89 billion yuan for the nine months ended Sept. 30, down 16.9% from the year-ago period, a Friday filing said.
The pharmaceutical company's injection, soft capsule, granule, and TCM formula granule products accounted for around 35.6%, 13.5%, 15.8%, and 28.5%, respectively, of the total turnover.
The company's shares were down over 1% in recent trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。